Guardant Health (GH) Stock Statistics & Valuation Metrics

Guardant Health has a market cap or net worth of $13.08B. The enterprise value is $13.38B.

Guardant Health has 132,599,930 shares outstanding. The number of shares has decreased by -2.65% in one year.

Guardant Health’s return on equity (ROE) is 4.19 and return on invested capital (ROIC) is -25.42%.

The current PE Ratio of Guardant Health is ―. Guardant Health’s PEG ratio is 4.56.

In the last 12 months, Guardant Health had revenue of 982.02M and earned -416.28M in profits. Earnings per share was -3.32.

In the last 12 months, operating cash flow was -175.41M and capital expenditures -49.43M, giving a free cash flow of -224.83M billion.

Guardant Health pays an annual dividend of ―, resulting in a dividend yield of ―

Guardant Health upcoming earnings date is Jul 30, 2026, After Close (Confirmed).

Guardant Health as a current ratio of 4.84, with Debt / Equity ratio of -925.88%

In the past 12 months, Guardant Health has paid -1.26M in taxes.

Guardant Health EV to EBITDA ratio is -37.74, with an EV/FCF ratio of -60.54.

Guardant Health has $1.10B in cash and marketable securities with $1.68B in debt, giving a net cash position of -$573.77M billion.

Gross margin is 64.90%, with operating margin of -44.43%, and net profit margin of -42.39%.

The average price target for Guardant Health is $128.88, which is 11.43% higher than the current price. The consensus rating is Strong Buy